Press "Enter" to skip to content

New patent for Novo Nordisk drug SAXENDA


Annual Drug Patent Expirations for SAXENDA
Annual Drug Patent Expirations for SAXENDA

Saxenda is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.

This drug has two hundred and one patent family members in twenty-four countries.

The generic ingredient in SAXENDA is liraglutide recombinant. One supplier is listed for this compound. Additional details are available on the liraglutide recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!